Information for Pharmacists
US$ 22.63
![glp-1 from china patent expiry and new GLP‑1 entries intensify global obesity drug fight Updated] GLP-1-RAs Swoop to Chinese](https://biz.chosun.com/resizer/v2/GFSDOZBQMEYTMNBQMM2TINJTGI.jpg?auth=aa3b4450df01a0ac69d0c51dd1ee7195b0ee2b400fc8942bf5a96f94aa5e48e4&width=616)
glp-1 from china patent expiry and new GLP‑1 entries intensify global obesity drug fight Updated] GLP-1-RAs Swoop to Chinese
Description
98.8% of customers buy 6 or more items
![glp-1 from china patent expiry and new GLP1 entries intensify global obesity drug fight Updated] GLP-1-RAs Swoop to Chinese](https://resource.chemlinked.com.cn/baipharm/articles/chinas-glp-1-ra-market-is-fueled-by-glycemic-control-weight-loss-needs.jpg)
Colorado Medicaid does not currently cover GLP-1 medications for weight loss
![glp-1 from china patent expiry and new GLP1 entries intensify global obesity drug fight Updated] GLP-1-RAs Swoop to Chinese](https://lookaside.fbsbx.com/lookaside/crawler/media/?media_id=954628003515540)
Unlike Sarahs experience with Semaglutide, Emily reported no adverse effects during her initial months on Tirzepatide
![glp-1 from china patent expiry and new GLP1 entries intensify global obesity drug fight Updated] GLP-1-RAs Swoop to Chinese](https://www.foodnavigator.com/resizer/v2/2QQUQSKUNFG2PN6MFIYMXUWEUA.jpg?auth=a6bd2731defc0ea5347e6d0562599077fb7790fc98ef36425651543f358110c3)
Obesity is driven by biology, genetics and the environment
![glp-1 from china patent expiry and new GLP1 entries intensify global obesity drug fight Updated] GLP-1-RAs Swoop to Chinese](https://i.guim.co.uk/img/media/61406cb96b360b405b1b6fef4bac88dadcbaf229/0_455_4284_3427/master/4284.jpg?width=1200&quality=85&auto=format&fit=max&s=cd2201d9cb47996f45112ed044d077a6)
Over time, this erosion leads to increased sensitivity, discoloration, rough or pitted tooth surfaces, higher cavity risk, and in severe cases, tooth fractures
![glp-1 from china patent expiry and new GLP1 entries intensify global obesity drug fight Updated] GLP-1-RAs Swoop to Chinese](https://lookaside.instagram.com/seo/google_widget/crawler/?media_id=3848565910852803829)
Even among those with payer approval, fewer than one in three prescriptions are ever filled due to patient abandonment, representing an additional 21% demand lost
![glp-1 from china patent expiry and new GLP1 entries intensify global obesity drug fight Updated] GLP-1-RAs Swoop to Chinese](https://www.reuters.com/resizer/v2/5LQRQPCDJRILNKQ7VTQVRSTR3Q.jpg?auth=13383a2b0e9aa12e31d1b29d76865b04ec712ccf5deb62f28cb874a7f2aec56f&height=1005&width=1920&quality=80&smart=true)